CVS Health launches company to produce cheaper 'biosimilar' versions of expensive biotech drugs

By Forbes
| August 25, 2023

The new company, Cordavis, will operate as 'a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products.'

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...